Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Industry Valuation for the Effervescent Tablet Sector?
In recent years, there has been a marked increase in the size of the effervescent tablet market. It’s expected to expand from $36.41 billion in 2024 to $39.6 billion in 2025, with a compound annual growth rate (CAGR) of 8.8%. The impressive growth seen in the historic period is due to factors such as initial innovations in pharmaceuticals, progress in medical fields, the rise of health trends among consumers, consumer comfort and preference, plus marketing and branding strategies.
Expectations for the effervescent tablet market project a swift expansion in the coming years. The market is predicted to escalate to “$59.67 billion by 2029, with a compound annual growth rate (CAGR) of 10.8%. Reasons for this surge in the forecast period include the preference for easier dosage forms, innovation in pharmaceutical concoctions, consumer interest in novelty, endorsements from health professionals, and shifts in demographics. The forecast period also anticipates major trends in market value configurations, cost motivators, expansion rate, distribution channels, and advances in technology.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8295&type=smp
What Forces Are Driving The Growth Of The Effervescent Tablet Market?
The effervescent tablets market is predicted to expand due to the high incidence rate of chronic illnesses. Chronic diseases typically last over three months and can deteriorate over time. The most common chronic conditions include cancer, heart disease, stroke, diabetes, and arthritis. Effervescent tablets serve as a powerful antioxidant in the treatment of chronic diseases like diabetes, cancer, and heart disease, enhancing blood antioxidant levels and lowering the chronic disease risk. For example, research from the American Cancer Society, a health organization based in the United States, revealed in January 2022 that the US is expected to see 609,360 cancer-related deaths and 1.9 million fresh cancer cases in 2022. This amounts to about 1,670 deaths every day. Hence, the significant incidence of chronic diseases is a driving force behind the growth of the effervescent tablets market.
How Is The Effervescent Tablet Industry Segmented Across Key Parameters?
The effervescent tablet market covered in this report is segmented –
1) By Product: Medication, Supplements
2) By Methods: Dry Methods, Wet Granulation
3) By Indication: Diuretics, Pain Management, Gastric Disorders, Respiratory Diseases, Other Indications
4) By Application: Dental Products, Dietary Supplements, Pharmaceutical, Other Applications
5) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Medication: Pain Relief Tablets, Cold And Flu Remedies, Digestive Health Tablets, Antacids
2) By Supplements: Vitamin And Mineral Supplements, Electrolyte Supplements, Herbal Supplements, Energy And Sports Supplements
What Are The Leading Trends And Opportunities In The Effervescent Tablet Sector?
The effervescent tablet market is increasingly influenced by the trend of technological innovations. The primary focus of significant players is the development of novel manufacturing techniques to maintain their market status. To illustrate, Health Innovations Ltd., a UK-based producer of healthcare supplements, introduced a patented technology called EfferShield in April 2022. This technology is applicable to effervescent tablets and powders and offers them in single-use pouches and stick-pack packaging. Such packaging is advantageous for consumers, offering flexibility, convenience, and potential for recycling and home-composting.
Which Companies Currently Dominate The Competitive Landscape In The Effervescent Tablet Industry?
Major companies operating in the effervescent tablet market are Bayer AG, Hermes Arzneimittel GmbH, GlaxoSmithKline PLC, Reckitt Benckiser Group PLC, Bristol-Myers Squibb Company, Bliss GVS Pharma Limited, Herbalife International Inc., Amerilab Technologies Inc., Pfizer Inc., Novartis AG, Perrigo Company PLC, Chiesi Farmaceutici SpA, SG Biopharm Pvt. Ltd., Tower Laboratories Ltd., American Health, By-health Co. Ltd., Vitabiotics Ltd., Prestige Brands Inc., Nuun and Company Inc., Amway Corp, GNC Holdings Inc., Sanofi SA, Merck KGaA, Roche Holding AG, Johnson & Johnson, Nestle SA, Dr Reddy’s Laboratories Ltd.
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/effervescent-tablet-global-market-report
Which Geographic Regions Are Driving Demand In The Effervescent Tablet Market?
North America was the largest region in the effervescent tablets market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the effervescent tablet market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=8295&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model